Clarus Therapeutics Holdings shares are trading lower amid profit taking. The stock surged on Tuesday after the company was granted a U.S. Patent.

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.